Sequence information
Variant position: 178 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 631 The length of the canonical sequence.
Location on the sequence:
ACGLLLGSTCGHWDIFSSWN
I SLPTVPKPPPKPPSPPAPGA
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human ACGLLLGSTCGHWDIFSSWNI SLPTVPKPPPKPPSPPAPGA
Mouse ACGLLLGSSCGHWDIFSTWNI SLPSVPKPPPKPPSPPAPGA
Bovine ACGLLLGSSCGHWDIFSSWNI SLPAVPKPPPQPPKPPAPGS
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
47 – 631
Sphingomyelin phosphodiesterase
Glycosylation
177 – 177
N-linked (GlcNAc...) asparagine
Mutagenesis
177 – 177
N -> G. Reduces protein levels. Reduces sphingomyelin phosphodiesterase activity. No effect on secretion.
Literature citations
Clinical findings in Niemann-Pick disease type B.
Muessig K.; Harzer K.; Mayrhofer H.; Kraegeloh-Mann I.; Haering H.-U.; Machicao F.;
Intern. Med. J. 36:135-136(2006)
Cited for: VARIANTS NPDB ARG-168 AND ASN-178; VARIANT GLY-507;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.